WhatDoTheyPrescribe.com is an educational resource explaining real-world prescribing patterns and is not a substitute for professional medical advice.

What do they prescribe?

Specify State (optional)

Search by Prescriber

Search by Drug

Doctors Who Prescribe Semaglutide (Ozempic, Rybelsus, Wegovy) in Nevada

Also known as: Ozempic, Rybelsus, Wegovy

Find doctors, physicians, and healthcare providers who prescribe Semaglutide in Nevada. This page lists the top prescribers of Semaglutide based on Medicare Part D data, including the number of claims, patients served, and total drug costs.

What is Semaglutide?

RYBELSUS and OZEMPIC tablets are indicated: • as an additional treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes. • to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal heart attack or non-fatal stroke) in adults with type 2 diabetes who are at high risk for these events. It belongs to a class of drugs known as glp-1 receptor agonist.

Total Claims in Nevada
48,211
0.7% of all Semaglutide prescriptions nationwide
Total Beneficiaries in Nevada
8,790
Total Cost in Nevada
$71,098,608

Top Prescribers in NV(1+)

Specify State (optional)

PrescriberLocationTypeClaimsBeneficiariesCost
Cres MirandaLas Vegas, NVCardiology943244$1,271,004
Loading more data in background...

Find Semaglutide doctors in other states

AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services.
Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.